结果:找到“ivol”相关内容9个,排序为按回复时间降序,搜索更多相关帖子请点击“高级
【月度】学术型和直观型股票博彩指数计算Stata代码(附2000-2021年数据)
4 个回复 - 4435 次查看 学术型和直观型股票博彩指数 学术型股票博彩指数计算 首先定义股票i在t月的均价Price,即个股月度成交金额与交易股数的比值。相较于收盘价,月度均价更能反映股票在月内的总体价位。然后构造股票的 ...2022-2-19 09:34 - momingqimiao7 - 现金交易版
沪深上市公司特质波动率年度数据2000-2021年
0 个回复 - 956 次查看 沪深上市公司特质波动率年度数据2000-2021年5w多条记录数2022-2-11 20:01 - lenosky - 现金交易版
沪深A股上市公司特质波动率Stata计算代码(附1990-2021年原始数据和结果)
12 个回复 - 5476 次查看 特质波动率 计算说明[hr] 首先用个股月内的日数据进行Fama-French三因素模型回归,回归公式如下 然后利用回归残差的样本标准差得到该股票在这个月的特质波动率。为了统一单位,我们将得到 ...2022-1-28 21:53 - momingqimiao7 - 现金交易版
Incentivology_The Forces That Explain Tremendous Success and Spectacular Failure
8 个回复 - 1501 次查看 Incentivology: The Forces That Explain Tremendous Success and Spectacular Failure by Jason Murphy (Author) About the Author Jason Murphy trained as an econo-mist and began his career at the Aust ...2019-7-20 19:48 - slowry - 金融学(理论版)
Rivoli - The Travels of a T-Shirt in the Global Economy An Economist Examines th
1 个回复 - 555 次查看 Rivoli - The Travels of a T-Shirt in the Global Economy An Economist Examines the Markets, Power, and Politics of World Trade - updated edition2018-8-27 20:03 - kawazhang - 商学院
Appendix 文件 Nivolumab plus Ipilimumab in Lung Cancer
5 个回复 - 659 次查看 【作者(必填)】Matthew D. Hellmann, M.D., Tudor-Eliade Ciuleanu, M.D., Adam Pluzanski, M.D., et al. 【文题(必填)】Appendix 文件 Nivolumab plus Ipilimumab in Lung Cancer (注:求appendix文件) 【年 ...2018-6-13 14:07 - ihc7788c - 求助成功区
Nivolumab plus Ipilimumab in Lung Cancer with a High Tumor Mutational Burden.
2 个回复 - 839 次查看 【作者(必填)】Matthew D. Hellmann, M.D., Tudor-Eliade Ciuleanu, M.D., Adam Pluzanski, M.D., et al. 【文题(必填)】Nivolumab plus Ipilimumab in Lung Cancer with a High Tumor Mutational Burden. 【年 ...2018-6-12 17:17 - ihc7788c - 求助成功区
Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma
1 个回复 - 643 次查看 【作者(必填)】Robert J. Motzer, M.D., Nizar M. Tannir, M.D., David F. McDermott, M.D., et al. 【文题(必填)】Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma 【年份(必填 ...2018-6-8 15:08 - ihc7788c - 求助成功区
Semivolatility of Returns as a Measure of Downside Risk
6 个回复 - 871 次查看 【作者(必填)】Donald R. Chambers and Qin Lu 【文题(必填)】Semivolatility of Returns as a Measure of Downside Risk 【年份(必填)】Vol. 19, No. 3, Winter 2017 【全文链接或数据库名称(选填)】http: ...2016-12-22 18:08 - lopemann - 求助成功区
Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
1 个回复 - 656 次查看 【作者(必填)】Wolchok JD1, Chiarion-Sileni V1, Gonzalez R1, Rutkowski P1, Grob JJ1, Cowey CL1, Lao CD1, Wagstaff J1, Schadendorf D1, Ferrucci PF1, Smylie M1,Dummer R1, Hill A1, Hogg D1, Haanen J1, Car ...2017-12-18 14:52 - ihc7788c - 求助成功区
Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma.
1 个回复 - 517 次查看 【作者(必填)】Weber J1, Mandala M1, Del Vecchio M1, Gogas HJ1, Arance AM1, Cowey CL1, Dalle S1, Schenker M1, Chiarion-Sileni V1, Marquez-Rodas I1, Grob JJ1,Butler MO1, Middleton MR1, Maio M1, Atkinson ...2017-12-18 14:54 - ihc7788c - 求助成功区
用EGARCH模型估计预期的特质波动率(FIVOL)
0 个回复 - 791 次查看 怎么预估相应时间段的股票波动率,需要用到什么数据以及命令。初次使用stata不太了解2021-5-19 22:21 - synewlife - Stata专版